Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Lantern Pharma Inc |
20/11 | 2,940 USD
-4,55% |
-4,55% |
|
Lantheus Holdings Inc |
20/11 | 86,450 USD
+8,84% |
+8,84% |
|
Larimar Therapeutics Inc |
20/11 | 6,080 USD
-4,70% |
-4,70% |
|
Leap Therapeutics Inc |
20/11 | 2,590 USD
-4,07% |
-4,07% |
|
Legend Biotech Corp |
20/11 | 40,140 USD
+4,53% |
+4,53% |
|
Lemaitre Vascular Inc |
20/11 | 103,440 USD
-0,29% |
-0,29% |
|
LENSAR Inc |
20/11 | 7,280 USD
-2,54% |
-2,54% |
|
Lexicon Pharmaceuticals Inc |
20/11 | 0,807 USD
-8,34% |
-8,34% |
|
Lifevantage Corporation |
20/11 | 12,930 USD
-4,65% |
-4,65% |
|
Ligand Pharmaceuticals, Inc. |
20/11 | 111,560 USD
-0,21% |
-0,21% |
|
Lineage Cell Therapeutics Inc |
20/11 | 0,641 USD
-28,99% |
-28,99% |
|
Lipocine Inc |
20/11 | 4,710 USD
-1,05% |
-1,05% |
|
Liquidia Corp |
20/11 | 10,120 USD
-0,39% |
-0,39% |
|
LivaNova PLC |
20/11 | 50,050 USD
-2,55% |
-2,55% |
|
Lixte Biotechnology Holdings Inc |
20/11 | 1,490 USD
-2,61% |
-2,61% |
Lumibird |
20/11 | 7,240 EUR
-1,36% |
-1,36% |
|
Lumos Pharma Inc |
20/11 | 4,320 USD
-0,23% |
-0,23% |
|
Lyra Therapeutics Inc |
20/11 | 0,178 USD
-9,04% |
-9,04% |